Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antigen-Presenting Cells"" wg kryterium: Temat


Tytuł:
Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System.
Autorzy:
Szczykutowicz J; Department of Biochemistry and Immunochemistry, Division of Chemistry and Immunochemistry, Wroclaw Medical University, Sklodowskiej-Curie 48/50, 50-369 Wroclaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 03; Vol. 24 (23). Date of Electronic Publication: 2023 Dec 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Galactose*
Antigen-Presenting Cells*/metabolism
Male ; Humans ; Ligands ; Macrophages/metabolism ; Lectins, C-Type/metabolism
Czasopismo naukowe
Tytuł:
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.
Autorzy:
Kulicke, Corinna A. (AUTHOR)
Swarbrick, Gwendolyn M. (AUTHOR)
Ladd, Nicole A. (AUTHOR)
Cansler, Meghan (AUTHOR)
Null, Megan (AUTHOR)
Worley, Aneta (AUTHOR)
Lemon, Chance (AUTHOR)
Ahmed, Tania (AUTHOR)
Bennett, Joshua (AUTHOR)
Lust, Taylor N. (AUTHOR)
Heisler, Chelsea M. (AUTHOR)
Huber, Megan E. (AUTHOR)
Krawic, Jason R. (AUTHOR)
Ankley, Laurisa M. (AUTHOR)
McBride, Savannah K. (AUTHOR)
Tafesse, Fikadu G. (AUTHOR)
Olive, Andrew J. (AUTHOR)
Hildebrand, William H. (AUTHOR)
Lewinsohn, Deborah A. (AUTHOR)
Adams, Erin J. (AUTHOR)
Pokaż więcej
Źródło:
Communications Biology. 2/24/2024, Vol. 7 Issue 1, p1-13. 13p.
Czasopismo naukowe
Tytuł:
CD4 T cells suppress EAE progression.
Autorzy:
Yang TT; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu PJ; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sun QY; Department of Anesthesiology, Chang Hai Hospital, Naval Military Medical University, Shanghai, China.
Wang ZY; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yuan GB; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Fan ZX; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma L; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Lu JF; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yuan BY; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zou WL; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao LM; Experimental Center, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Li Q; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Liu GZ; Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 15; Vol. 14 (1), pp. 6262. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalomyelitis, Autoimmune, Experimental*
Multiple Sclerosis*
Mice ; Animals ; T-Lymphocytes, Regulatory ; Spinal Cord/pathology ; Antigen-Presenting Cells ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route.
Autorzy:
Xu, Zhengzhong (AUTHOR)
Li, Xin (AUTHOR)
Xia, Aihong (AUTHOR)
Zhang, Zhifang (AUTHOR)
Wan, Jiaxu (AUTHOR)
Gao, Yan (AUTHOR)
Meng, Chuang (AUTHOR)
Chen, Xiang (AUTHOR)
Jiao, Xin-an (AUTHOR)
Pokaż więcej
Źródło:
BMC Immunology. 11/27/2023, Vol. 24 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells.
Autorzy:
Choi KC; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Lee DH; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Lee JW; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Lee JS; Regeneration Medicine Research Center, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea.
Lee YK; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Choi MJ; Division of Hematology/Oncology, Brown University and Rhode Island Hospital, Providence, RI 02903, USA.
Jeong HY; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Kim MW; Division of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Lee CG; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Park YS; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 23; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Nanoparticles*/chemistry
Vaccines*
Liposomes*
Animals ; Mice ; RNA, Messenger/chemistry ; mRNA Vaccines ; Transfection ; Antigen-Presenting Cells
Czasopismo naukowe
Tytuł:
Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.
Autorzy:
Wang P; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Fredj Z; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Zhang H; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Rong G; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Bian S; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Sawan M; CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2024 Jan 17; Vol. 2024, pp. 2313062. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD28 Antigens*
Antibodies*
Antigen-Presenting Cells ; Peptides ; Superantigens
Czasopismo naukowe
Tytuł:
Eosinophils Contribute to Oral Tolerance via Induction of RORγt-Positive Antigen-Presenting Cells and RORγt-Positive Regulatory T Cells.
Autorzy:
Kurihara S; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Suzuki K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Yokota M; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Ito T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba 260-8670, Japan.
Hayashi Y; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Kikuchi R; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Kageyama T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Meguro K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Tanaka S; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Iwata A; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Goto Y; Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba 260-8670, Japan.; Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba 260-8670, Japan.; Division of Pandemic and Post-Disaster Infectious Diseases, Research Institute of Disaster Medicine, Chiba University, Chiba 260-8670, Japan.; Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba 260-8670, Japan.
Suto A; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.
Nakajima H; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba 260-8670, Japan.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Jan 10; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Nuclear Receptor Subfamily 1, Group F, Member 3*/genetics
Eosinophils*
Animals ; Mice ; T-Lymphocytes, Regulatory ; Immunity, Innate ; Lymphocytes ; Antigen-Presenting Cells
Czasopismo naukowe
Tytuł:
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.
Autorzy:
Galpin KJC; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Rodriguez GM; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Maranda V; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Cook DP; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Macdonald E; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Murshed H; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Zhao S; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
McCloskey CW; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Chruscinski A; Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.
Levy GA; Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.
Ardolino M; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Vanderhyden BC; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. .; Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 08; Vol. 14 (1), pp. 787. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Fibrinogen*
Melanoma*/genetics
Melanoma*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Animals ; Female ; Humans ; Mice ; Antigen-Presenting Cells ; Carcinoma, Ovarian Epithelial ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning.
Autorzy:
Zhou W; BGI Research, Shenzhen, 518103, China.; College of Life Sciences, South China Agricultural University, Guangzhou, 510642, China.
Chen Y; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China.
Zheng Y; BGI Research, Shenzhen, 518103, China.; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
Bai Y; BGI Research, Shenzhen, 518103, China.
Yin J; BGI Research, Shenzhen, 518103, China.
Wu XX; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China.
Hong M; College of Life Sciences, South China Agricultural University, Guangzhou, 510642, China.; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, South China Agricultural University, Guangzhou, 510642, China.
Liang L; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.; BGI Research, Qingdao, 266555, China.
Zhang J; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China.
Gao Y; BGI Research, Shenzhen, 518103, China.
Sun N; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China.
Li J; BGI Research, Shenzhen, 518103, China.
Zhang Y; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China.
Wu L; Department of Obstetrics, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, China. .
Jin X; BGI Research, Shenzhen, 518103, China. .; School of Medicine, South China University of Technology, Guangzhou, 510006, China. .; Shenzhen Key Laboratory of Transomics Biotechnologies, BGI-Shenzhen, Shenzhen, 518083, China. .
Niu J; Department of Obstetrics, Shenzhen Maternity & Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, 518028, China. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Jan 05; Vol. 7 (1), pp. 32. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pre-Eclampsia*/diagnosis
Pre-Eclampsia*/genetics
Female ; Pregnancy ; Humans ; Antigen-Presenting Cells ; Machine Learning ; Transcriptome ; Sequence Analysis, RNA
Czasopismo naukowe
Tytuł:
Restoring tolerance with antigen delivery.
Autorzy:
Jabri B; Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Department of Medicine, Chicago, IL, USA.; University of Chicago Celiac Disease Center, Chicago, IL, USA.; University of Chicago Committee on Immunology, Chicago, IL, USA.; University of Chicago Department of Pathology, Chicago, IL, USA.
Abadie V; Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Department of Medicine, Chicago, IL, USA.; University of Chicago Celiac Disease Center, Chicago, IL, USA.; University of Chicago Committee on Immunology, Chicago, IL, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Jan 05; Vol. 383 (6678), pp. 30-32. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Autoimmune Diseases*/therapy
Autoantigens*/administration & dosage
Autoantigens*/immunology
Desensitization, Immunologic*/methods
Self Tolerance*
Autoimmunity ; Antigen-Presenting Cells/immunology ; Antigen Presentation ; Humans ; Animals ; Mice
Czasopismo naukowe
Tytuł:
Molecular Characteristics, Functional Definitions, and Regulatory Mechanisms for Cross-Presentation Mediated by the Major Histocompatibility Complex: A Comprehensive Review.
Autorzy:
Liu S; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Wei S; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Sun Y; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Xu G; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Zhang S; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Li J; Engineering Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Institute of Animal Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 22; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cross-Priming*
Histocompatibility Antigens*
Animals ; Major Histocompatibility Complex ; Antigen-Presenting Cells ; Histocompatibility Antigens Class I
Czasopismo naukowe
Tytuł:
Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production.
Autorzy:
Guo Y; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Tong C; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Wu Z; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Lu Y; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Wang Y; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Han W; Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Pokaż więcej
Źródło:
Cancer biology & medicine [Cancer Biol Med] 2023 Nov 06; Vol. 20 (11).
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms*/therapy
Humans ; Antigen-Presenting Cells ; T-Lymphocytes ; Immunity
Raport
Tytuł:
A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.
Autorzy:
Kuczkowska K; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway. .
Bjerkan L; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Stubsrud E; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Husbyn HC; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Chellappa S; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.; Veterinærinstituttet, Elizabeth Stephansens Vei 1, 1433, Ås, Norway.
Hauge A; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Skarshaug R; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Torgersen ML; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Heim JB; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Jørgensen MJ; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Wold CW; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Schleimann MH; Department of Clinical Medicine/Infectious Diseases, Aarhus University, Palle Juul-Jensens Boulevard 45, 8200, Aarhus N, Denmark.
Tolstrup M; Department of Clinical Medicine/Infectious Diseases, Aarhus University, Palle Juul-Jensens Boulevard 45, 8200, Aarhus N, Denmark.
Granum S; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Fredriksen AB; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Pedersen MW; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Norheim G; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 02; Vol. 13 (1), pp. 18902. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Vaccines, DNA*
COVID-19*/prevention & control
Cancer Vaccines*
Animals ; Humans ; Mice ; COVID-19 Vaccines ; SARS-CoV-2 ; Pandemics ; T-Lymphocytes ; Antigen-Presenting Cells ; Broadly Neutralizing Antibodies ; DNA ; Immunoglobulin G ; Antibodies, Neutralizing ; Antibodies, Viral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Central tolerance is impaired in the middle-aged thymic environment.
Autorzy:
Lancaster JN; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Keatinge-Clay DE; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Srinivasan J; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Li Y; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Selden HJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Nam S; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Richie ER; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ehrlich LIR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2022 Jun; Vol. 21 (6), pp. e13624. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antigen-Presenting Cells*/metabolism
Central Tolerance*
Autoantigens/metabolism ; Epithelial Cells/metabolism ; T-Lymphocytes, Regulatory ; Thymocytes ; Thymus Gland
Czasopismo naukowe
Tytuł:
Determining if T cell antigens are naturally processed and presented on HLA class I molecules.
Autorzy:
Friedman J; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 7N240C, Bethesda, MD, 20892, USA.
Gunti S; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 7N240C, Bethesda, MD, 20892, USA.
Lee M; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 7N240C, Bethesda, MD, 20892, USA.
Bai K; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 7N240C, Bethesda, MD, 20892, USA.
Hinrichs C; Rutgers Cancer Center at Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
Allen CT; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 7N240C, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2022 Feb 11; Vol. 23 (1), pp. 5. Date of Electronic Publication: 2022 Feb 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Antigen Presentation*
Antigen-Presenting Cells*
Antigens, Neoplasm ; B-Lymphocytes ; Epitopes ; Epitopes, T-Lymphocyte ; T-Lymphocytes
Czasopismo naukowe
Tytuł:
Targeted Delivery of Immunostimulatory CpG Oligodeoxynucleotides to Antigen-Presenting Cells in Draining Lymph Nodes by Stearic Acid Modification and Nanostructurization.
Autorzy:
Nagaoka M; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Chiba, Japan.
Liao W; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Chiba, Japan.
Kusamori K; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Chiba, Japan.
Nishikawa M; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Chiba, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 25; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Antigen-Presenting Cells/*metabolism
Nanostructures/*chemistry
Oligodeoxyribonucleotides/*pharmacology
Adjuvants, Immunologic/pharmacology ; Animals ; Antigen-Presenting Cells/drug effects ; DNA/immunology ; Drug Delivery Systems/methods ; Female ; Immunization/methods ; Lymph Nodes/drug effects ; Lymph Nodes/immunology ; Lymph Nodes/metabolism ; Mice ; Mice, Inbred C57BL ; Nanostructures/therapeutic use ; Nucleic Acid Conformation/drug effects ; Oligodeoxyribonucleotides/administration & dosage ; Oligodeoxyribonucleotides/metabolism ; Proof of Concept Study ; RAW 264.7 Cells ; Stearic Acids/chemistry
Czasopismo naukowe
Tytuł:
TLR2 and TLR4 molecules and antigen-presenting cell compositions in cecal tonsils of broiler chicks (Gallus gallus domesticus) in the first two weeks of the post-hatch period.
Autorzy:
Eren U; Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Aydin Adnan Menderes, Aydin, Turkey.
Kum S; Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Aydin Adnan Menderes, Aydin, Turkey.
Nazligul A; Department of Animal Sciences, Faculty of Veterinary Medicine, University of Aydin Adnan Menderes, Aydin, Turkey.
Gules O; Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Afyon Kocatepe, Afyon, Turkey.
Aka E; Department of Histology and Embryology, Institute of Health Sciences, University of Aydin Adnan Menderes, Aydin, Turkey.
Yildiz M; Department of Occupational Health and Safety, Can School of Applied Sciences, Canakkale Onsekiz Mart University, Canakkale, Turkey.
Zorlu S; Department of Histology and Embryology, Institute of Health Sciences, University of Aydin Adnan Menderes, Aydin, Turkey.
Pokaż więcej
Źródło:
Anatomia, histologia, embryologia [Anat Histol Embryol] 2022 Jan; Vol. 51 (1), pp. 125-135. Date of Electronic Publication: 2021 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antigen-Presenting Cells*
Chickens*
Toll-Like Receptor 2*
Toll-Like Receptor 4*
Palatine Tonsil/*cytology
Animals ; Cecum
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies